What is Sensorium Therapeutics?
Sensorium Therapeutics is a clinical-stage biotechnology company leveraging artificial intelligence for drug discovery. The company focuses on creating novel, nature-inspired therapies targeting neurological and psychiatric conditions such as anxiety, epilepsy, and Alzheimer's disease. Its AI-driven approach aims to accelerate the development of treatments for complex brain disorders, positioning it at the forefront of neurotherapeutics innovation.
How much funding has Sensorium Therapeutics raised?
Sensorium Therapeutics has raised a total of $55M across 2 funding rounds:
Series A
$30M
Series A
$25M
Series A (2022): $30M with participation from Route 66 Ventures, Santé Ventures, and CU Healthcare Innovation Fund
Series A (2025): $25M led by Mission BioCapital, Mockingbird Credit Partners, Dolby Family Ventures, and Hatteras Venture Partners
Key Investors in Sensorium Therapeutics
Route 66 Ventures
Route 66 Ventures is a private investment firm focused on helping entrepreneurs shape the financial services landscape of tomorrow by providing Venture Capital and Credit solutions to emerging financial technology and services companies.
Santé Ventures
Santé Ventures is a privately held company that invests in innovative healthcare enterprises, focusing on Biotech, Medtech, and Healthtech sectors. The company manages over 1 billion in capital to improve patient health outcomes through strategic investments in emerging technologies.
Mission BioCapital
Mission BioCapital is a venture capital firm that provides early-stage capital to innovative life science entrepreneurs, focusing on empowering startups through mentorship and collaboration.
What's next for Sensorium Therapeutics?
The recent major strategic investment signals a pivotal growth phase for Sensorium Therapeutics, likely enabling the company to advance its pipeline candidates through clinical trials and scale its AI discovery platform. This infusion of capital is expected to bolster research and development efforts, potentially leading to key milestones in the treatment of debilitating brain and mental health conditions. The company's focus on nature-inspired, AI-driven solutions suggests a strategic direction towards sustainable and effective therapeutic development.
See full Sensorium Therapeutics company page
